Gennex Laboratories (BOM:531739) Tariff Resilience Score: 0/10 (As of Aug. 14, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:531739 Gennex Laboratories Ltd BOM:531739
79 GF Score
Price ₹9.55
GF Value ₹15.64
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is Gennex Laboratories Tariff Resilience Score?

Gennex Laboratories has the Tariff Resilience Score of 0, which implies that the company might have .

Gennex Laboratories has

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Gennex Laboratories might have .

Gennex Laboratories  (BOM:531739) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Gennex Laboratories Tariff Resilience Score Related Terms

BOM:531739
79GF Score
Gennex Laboratories Ltd BOM:531739
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Gennex Laboratories (BOM:531739) Overvalued in 2026?

Based on GuruFocus' analysis, Gennex Laboratories stock appears to be undervalued. The current stock price of ₹9.55 is trading 38.9% below its estimated GF Value™ of ₹15.64. GuruFocus considers Gennex Laboratories to be Possible Value Trap.

Key valuation signals for BOM:531739:

  • Tariff Resilience Score: 0
  • GF Value™: ₹15.64 vs. price of ₹9.55 (38.9% below fair value)
  • GF Score™: 79/100 with 7 warning signs

No single metric tells the full story. See the BOM:531739 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Gennex Laboratories Business Description

Address Akash Ganga, Plot No. 144, 4th Floor, Srinagar Colony, Hyderabad, TG, IND, 500 073
Gennex Laboratories Ltd is engaged in the manufacturing of bulk drugs, and intermediates, Biotech Products. Geographically, the group has a business presence in Bangladesh, Egypt, Germany, Guatemala, Iran, Israel and other countries. Its products include Guaifenesin, Methocarbamol, Fluconazole and Phenazopyridine, among others.
79GF Score

Get the complete analysis for BOM:531739

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹9.55
Price
₹15.64
GF Value